Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG‐IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4...

Full description

Saved in:

Bibliographic Details
Published in:	Liver transplantation Vol. 12; no. 12; pp. 1805 - 1812
Main Authors:	Fernández, Inmaculada, Meneu, Juan Carlos, Colina, Francisco, García, Ignacio, Muñoz, Raquel, Castellano, Gregorio, Fuertes, Antonio, Abradelo, Manuel, Lumbreras, Carlos, Moreno, Enrique, Solís‐Herruzo, José Antonio
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-12-2006
Subjects:	Adult Alanine transaminase alpha -Interferon Antiviral Agents - therapeutic use Biopsy Drug Therapy, Combination Female Fibrosis gamma-Glutamyltransferase - blood Graft rejection Hepacivirus - drug effects Hepacivirus - isolation & purification Hepatitis C Hepatitis C - drug therapy Hepatitis C - pathology Hepatitis C virus Humans Inflammation Interferon Interferon-alpha - therapeutic use Kidney Failure, Chronic - surgery Kidney Failure, Chronic - virology Liver Transplantation Male Middle Aged Polyethylene Glycols Recombinant Proteins Recurrence Ribavirin Ribavirin - therapeutic use RNA RNA viruses RNA, Viral - blood Side effects Toxicity Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!